[CUV] YoY Quarter Result on 31-Dec-2023 [#Q2]

Stock
[CUV] Clinuvel Pharmaceuticals Limited
Announcement Date
29-Dec-2023
Financial Year
2024
Quarter
31-Dec-2023 [#Q2]
Profit Trend
QoQ- -43.09%
YoY- -3.97%
Quarter Report
CUV's Result
CUV's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 32,257 29,355 24,631 15,743 9,971 8,981 7,070 28.77%
PBT 14,806 14,600 8,726 5,811 1,059 4,076 1,411 47.93%
Tax 3,870 3,212 2,855 -676 -1,116 0 -31 -
NP 10,936 11,388 5,870 6,487 1,059 4,076 1,442 40.14%
Tax Rate -26.14% -22.00% -32.72% 11.64% 105.36% 0.00% 2.20% -
Total Cost 21,321 17,967 18,761 9,256 8,912 4,906 5,628 24.84%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin 33.90 38.79 23.83 41.21 10.62 45.38 20.40 8.82%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS 0.22 0.23 0.12 0.13 0.02 0.08 0.03 39.36%
EPS Diluted 0.21 0.22 0.11 0.13 0.02 0.08 0.03 38.28%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.